Immunopathology
Immunopathology
批准号:
7680751
负责人:
Robert B Colvin
金额:
$21.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-15 至 2014-04-30
关键词:
AcuteAdhesionsAllograftingAnimalsAntibodiesApoptosisAutopsyCellsChronicComplementDNA FragmentationElectron MicroscopyEventFertilizationFormalinFreezingGlutaralHeartHistologyImageImmunofluorescence ImmunologicImmunoglobulin DepositionImmunohistochemistryImmunoperoxidase TechnicsIn Situ Nick-End LabelingIndividualInflammationInflammatoryInjuryKidneyLesionLocationLungMolecularNatureOrganOrgan TransplantationParaffinParaffin EmbeddingPathologistPathologyProcessProtocols documentationReceptor ActivationResearch DesignRoleSamplingSlideStaining methodStainsTechniquesTissue BankingTissue BanksTissue SampleTissuesToxic effectTransplantationcell injurycell typecomplement C4dcytokinedigitaldigital imagingeponimmunopathologyinsightintervention effectlight microscopylymph nodesmorphometrynovelnovel strategiesparaformprogramsresearch study
中文摘要
所有研究的病理学特征将由同一组病理学家进行评估和分级,我们认为这是该计划项目的重要资产。抗体和细胞因子探针组也将尽可能具有可比性。这将通过扩展新的发现促进项目之间的交叉施肥,并通过比较和对比不同物种和不同器官之间的移植物,深入了解一个项目中结果的一般意义。我们也有一个很好的注释食蟹猴组织库的冷冻和石蜡包埋组织可从我们以前的移植
实验(>5000个样本),可以利用这些实验来扩展和完善我们的分析。
将使用的技术包括常规组织学、免疫组织化学、免疫荧光、电子显微镜和数字载玻片成像形态测定法。使用一组mAb的免疫过氧化物酶技术将区分浸润细胞类型、粘附和细胞因子分子和受体以及活化标志物。免疫荧光将用于定位免疫球蛋白和补体的沉积,
以及使用数字成像对细胞标记进行双重/三重染色。C4d染色将用于检测体液排斥反应。凋亡/DNA片段化标记物(TUNEL)将评估细胞损伤。协议在每个项目中都有详细说明。
核心的病理学研究对于评估器官移植物(心脏、肺和心脏)的状态至关重要。
肾)和干预减少炎症和实质损伤的效果。这些研究
确定浸润移植物的细胞的性质和位置,抗体在排斥反应中的作用,
和治疗的全身毒性。病理结果将与功能和分子相关
在项目和其他核心中进行的研究。此外,将对所有动物进行完整尸检,
通过所示的常规和特殊技术分析所有主要器官的样品。
我们将比较不同方案中同种异体移植物的炎症分子和细胞事件。串行
从移植当天开始,将对移植物和淋巴结的样本进行评估,
治疗和耐受诱导的作用机制。免疫病理学研究是
设计用于光学显微镜处理的最少组织样本(2个小块,通常为2x2 x2 mm)
用福尔马林/石蜡技术和戊二醛/多聚甲醛/epon进行免疫组化,
一微米切片和电子显微镜。
英文摘要
The pathology features will be assessed and graded by the same group pathologists for all studies, which we consider an important asset of the Program Project. The panel of antibodies and cytokine probes will also be comparable, whenever possible. This should promote cross-fertilization among the projects by extension of novel findings and provide insights into the general significance of the results in one project by comparing and contrasting grafts in different species and between different organs. We also have a well annotated Cynomolgus tissue bank of frozen and paraffin embedded tissue available from our previous transplantation
experiments (>5000 samples), which can be drawn upon to expand and refine our analysis.
The techniques that will be utilized include routine histology, immunohistochemistry, immunofluorescence, electron microscopy and digital slide imaging morphometry. Immunoperoxidase techniques with a panel of mAbs will distinguish the infiltrating cell types, adhesion and cytokine molecules and receptors, and activation markers. Immunofluorescence will be used to localize the deposition of immunoglobulin and complement, as
well as double/triple staining for cell markers using digital imaging. C4d stains will be used to detect humoral rejection. Markers of apoptosis/DNA fragmentation (TUNEL) will assess cell injury. The protocols are given in detail in each of the individual Projects.
The pathology studies in the Core are essential to evaluate the status of the organ allografts (heart, lung and
kidney) and the effects of the intervention to reduce inflammation and parenchymal injury. The studies are
critical to determine the nature and location of the cells infiltrating the graft, the role of antibodies in rejection
and systemic toxicity of treatment. The pathology results will be correlated with functional and molecular
studies done in the projects and other cores. In addition, complete necropsies will be done on all animals, with
samples from all major organs analyzed by routine and special techniques as indicated.
We will compare the inflammatory molecular and cellular events in allografts in the different protocols. Serial
samples of the graft and lymph nodes, starting on the day of transplant, will be assessed to provide insights
into mechanisms of action of the treatment and tolerance induction. The immunopathologic studies are
designed with a minimum of tissue sample (2 small blocks, typically 2x2x2 mm) processed for light microscopy
and immunohistochemistry with formalin/paraffin techniques and in glutaraldehyde/paraformaldehyde/epon for
one-micron sections and electron microscopy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunopathologic Studies
-
批准号:8432088
-
项目类别:
-
资助金额:$13.31万
-
财政年份:2012
-
负责人:Robert B Colvin
-
依托单位:
Immunopathologic Studies
-
批准号:8725788
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2012
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8071240
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8260821
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Pathology
-
批准号:8134128
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:8462892
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of Acceptance in Mouse Renal Allografts
-
批准号:7985705
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2010
-
负责人:Robert B Colvin
-
依托单位:
Mechanisms of acceptance of mouse renal allografts
-
批准号:7848042
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2009
-
负责人:Robert B Colvin
-
依托单位:
Core--Pathology
-
批准号:7009886
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2005
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6580448
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2002
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6445528
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6302105
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2000
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6296843
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6109465
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Robert B Colvin
-
依托单位:
CORE--IMMUNOPATHOLOGY
-
批准号:6272551
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1998
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:3532786
-
项目类别:
-
资助金额:$6.49万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:3532788
-
项目类别:
-
资助金额:$15.72万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
IMMUNOLOGY AND TUMORS
-
批准号:2085079
-
项目类别:
-
资助金额:$16.46万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY
-
批准号:2085080
-
项目类别:
-
资助金额:$17.77万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY
-
批准号:2085081
-
项目类别:
-
资助金额:$12.88万
-
财政年份:1978
-
负责人:Robert B Colvin
-
依托单位:
海外基金